Core Viewpoint - AIA Group (01299.HK) shows significant bullish signs in its stock price, driven by multiple technical indicators improving simultaneously, suggesting potential trading opportunities for investors [1][4]. Technical Analysis - AIA's stock price is currently at HKD 69.35, with a decline of 4.15%. The 5-day volatility is at 3.2%, indicating a neutral range, while the trading volume reached HKD 1.902 billion, reflecting high market participation [1]. - The 10-day moving average (MA10) has risen to HKD 70.19, crossing above the 30-day (HKD 68.04) and 60-day (HKD 63) moving averages, forming a "golden cross" and indicating a potential mid-term upward trend [1]. - The stock price has established a clear support level below the first resistance at HKD 73.9. A successful breakout above this level could target HKD 76.2, while short-term support levels are at HKD 67.3 and HKD 69.6 [4]. Derivative Products Performance - Leveraged products related to AIA have shown significant amplification effects. For instance, HSBC's bull certificate (55603) and UBS's bull certificate (55450) recorded gains of 14%, maintaining a leverage ratio of approximately 5 times [1]. - Notably, UBS's call option (13504) surged by 22%, and Bank of China's call option (28665) increased by 24%, with leverage effects reaching 8-9 times, outperforming bull certificates [2]. Market Sentiment and Strategy - The overall technical indicators provide a strong buy signal, with a composite strength score of 16, indicating a bullish consensus among most indicators. The RSI is at 66, suggesting the upward momentum is still intact despite entering the overbought territory [4][7]. - The current market environment is favorable for price consolidation at high levels, with short-term investors considering derivative products for aggressive strategies. The volatility increase and market uncertainty make selecting appropriate call or bull certificates crucial for participating in potential upward movements while managing risks [7][8]. Options and Certificates - Among the available call options, the Bank of China's option (28665) has a leverage of 9.8 times with a strike price of HKD 73.15, while UBS's option (13504) has a leverage of 8.8 times with a slightly lower strike price of HKD 72.05. Both options are set to expire in September 2025, making them suitable for short to medium-term bullish strategies [8]. - In the bull certificate category, UBS's (55450) and HSBC's (55603) products have a redemption price of HKD 60, with actual leverage ratios of 5.3 and 5.5 times, respectively. These certificates are considered stable tools for participating in upward trends, especially if the stock price holds above the HKD 70 support level [8].

Market Overview - The Hang Seng Index is facing resistance at 24,700 points, with a projected P/E ratio of 11 times over the next 12 months, following a reduction in tariffs between the US and China [2] - The market sentiment remains cautious due to limited progress in US-China trade talks and a lack of significant economic stimulus from mainland China [2] Macro Focus - The Caixin China Services PMI fell to 50.6 in June, below expectations, indicating a slowdown in service sector expansion [3][8] - Retail sales of new energy vehicles in China increased by 25% year-on-year in June, with a penetration rate of 52.7% [8] - The Ministry of Commerce plans to strengthen guidance on second-hand vehicle exports, aiming to support the development of the second-hand car market [8] - The Macau gaming sector saw a 19% year-on-year increase in June gaming revenue, exceeding expectations [6] Company News - Alibaba issued over 12 billion HKD in zero-coupon convertible bonds for Alibaba Health [3] - Geely Auto is entering the Italian market, while XPeng's G7 model starts at 195,800 RMB [3] - HSBC Holdings sold its UK insurance business for approximately 260 million GBP [3] Industry Insights - The biotechnology sector is expected to benefit from new measures supporting the high-quality development of innovative drugs [6] - The textile industry anticipates improved orders as Nike's performance is expected to stabilize [6] - The solar industry is facing challenges due to low-price competition, prompting the Ministry of Industry and Information Technology to call for comprehensive governance [9] IPO Market - KPMG estimates that the total amount raised from new IPOs in Hong Kong could reach up to 250 billion HKD this year, with over 200 applications currently being processed [9]

Core Viewpoint - China Life Insurance Company Limited is establishing a partnership with China Nuclear Power and the China-Russia Nuclear Industry Fund to create a partnership enterprise with a total capital contribution of RMB 1.501 billion, where China Life will contribute RMB 1.2 billion [2][3][7]. Group 1: Partnership Agreement - The partnership will include China Life Insurance, China Nuclear Power, and the China-Russia Nuclear Industry Fund as limited partners, while Guangzhou Jinhong and the China Nuclear Fund will act as general partners [3][6]. - The total capital contribution from all partners is RMB 1,501,000,000, with specific contributions detailed as follows: - Guangzhou Jinhong: RMB 1,000,000 - China Nuclear Fund: RMB 1,000,000 - China Life: RMB 1,200,000,000 - China Nuclear Power: RMB 279,000,000 - China-Russia Nuclear Industry Fund: RMB 20,000,000 [3][4]. Group 2: Investment Strategy - The partnership enterprise aims to invest in domestic nuclear power companies involved in the development, investment, construction, and operation of nuclear power projects, contributing to China's clean and low-carbon energy development [5][6]. - The investment period for the partnership is set for six years, followed by a four-year exit period, with the possibility of extending the duration if necessary [5]. Group 3: Management and Fees - Guoshou Jingshi will serve as the manager of the partnership, providing daily operational and investment management services, with an annual management fee of 0.1% of the total capital contributions [6][8]. - An investment decision committee will be established to oversee investment and exit decisions, while an investment advisory committee will evaluate potential conflicts of interest and compliance with regulations [6][7]. Group 4: Rationale for the Transaction - The investment in nuclear assets is expected to provide long-term, stable dividend returns, aligning with the company's strategy to enhance long-term investment returns and support green finance initiatives [7][8]. - The transaction is deemed fair and reasonable, conducted under normal commercial terms, and is in the overall interest of the company and its shareholders [7].

Core Viewpoint - China Life Insurance (02628.HK) is experiencing a strong upward trend in its stock price, currently at 17.16 HKD, reflecting a 1.06% increase, following a rebound from a short-term support level of 16.2 HKD [1] Technical Analysis - The stock price has surpassed all major technical moving averages, including the 10-day moving average at 16.4 HKD, the 30-day moving average at 15.63 HKD, and the 60-day moving average at 15.23 HKD, indicating a bullish structure [1] - The stock is approaching the first resistance level at 17.3 HKD, with a potential target of 18.3 HKD if this level is breached [2] - The recent volatility is reflected in a 6.8% fluctuation over five days, with an RSI index at 72, indicating a technical overbought condition [3] - The overall technical indicators are rated as "strong buy," with a signal strength of 16 points, supported by bullish momentum across all categories [3] - The MACD has completed a golden cross and maintains an expanding trend, supporting a continued upward pattern [3] - The price has successfully broken through the Ichimoku cloud, suggesting further upward potential in the coming weeks [3] Derivative Products Performance - On June 6, China Life's related structured products performed well, with a 2.76% increase in the underlying stock, leading to significant gains in derivatives [4] - The Societe Generale bull certificate (53998) led with a 15% increase, outperforming the underlying stock, showcasing the leverage advantage of bull certificates in rising markets [4] Investment Options - Current market conditions provide diverse investment options through China Life's related structured products, with call options offering a leverage of 4.1 times [7] - Bull certificates from HSBC (53706) and JPMorgan (53835) offer over 5 times actual leverage, with a buyback price set at 14 HKD [7] - For bearish strategies, Citigroup's bear certificate (56865) offers a leverage of 4.7 times, with a buyback price set at 20 HKD, providing a favorable risk-reward ratio [7] Summary - China Life is in a healthy upward phase with strong volume-price support and trend indicator resonance, but caution is advised due to potential overbought conditions and divergence risks [10]

Group 1: Hang Seng Index - Investors believe that the Hang Seng Index may not hold above 23,300, with potential declines to 22,000-22,700 [1] - Technical analysis indicates a "sell" signal with 10 sell signals, 7 buy signals, and 7 neutral signals [1] - The current market price is at the middle line of the Bollinger Bands, suggesting a slight bearish bias [1] Group 2: Tencent Holdings (00700) - Bearish investors expect the stock to test support at 495 HKD, with further support at 470-450 HKD [3] - The technical summary shows 11 sell signals and 4 buy signals, indicating a bearish sentiment [3] - The support level is identified at 483 HKD, which is also the lower band of the Bollinger Bands [3] Group 3: Kuaishou-W (01024) - Bullish investors believe that if the stock holds above 54 HKD, it could challenge 60 HKD [6] - The technical summary indicates a "buy" signal with 14 buy signals and 3 sell signals [6] - Resistance levels are noted at 55.7 HKD and 57.5 HKD, with the upper Bollinger Band at 55.5 HKD [6] Group 4: AIA Group (01299) - Some investors are optimistic about the stock challenging the 70-75 HKD range, while bearish investors expect a drop to 55 HKD [8] - Resistance levels are identified at 67.4 HKD and 69.8 HKD, both below 70 HKD [8] - The technical analysis leans towards a "buy" signal based on daily trends [8] Group 5: Hua Hong Semiconductor (01347) - Investors are questioning whether the stock will challenge the 33-36 HKD range, with some bearish investors targeting 31 HKD [12] - The technical summary shows a "buy" signal with 10 buy signals, 8 sell signals, and 6 neutral signals [12] - Resistance levels are at 33.6 HKD and 36.6 HKD, closely aligning with investor expectations [12] Group 6: Zijin Mining (02899) - Investors are optimistic about valuation increases due to movements in gold and copper, despite some bearish sentiment expecting a drop to 14 HKD [15] - The closing price has fallen below the middle line of the Bollinger Bands, raising concerns about further declines [15] - The short-term technical signal is a "sell," with support levels at 17 HKD and 16.3 HKD [15]

Core Viewpoint - China Life Insurance (02628) is experiencing a strong upward trend in its stock price, with a current price of 16.04 HKD and a daily increase of 1.78%, supported by multiple technical indicators signaling a "strong buy" despite being in an overbought state [1][4]. Technical Analysis - The technical indicators for China Life show a strong bullish pattern, with several moving averages indicating buy signals: MA10 at 15.79 HKD, MA30 at 14.72 HKD, and MA60 at 15.08 HKD, with the current price above these averages [1]. - The RSI index is at 66, indicating an overbought condition, while the William's indicator also signals a buy. Other indicators like ADX, psychological line, and momentum oscillators support a bullish outlook, although the overbought status suggests potential short-term pullback risks [1]. Support and Resistance Levels - The first short-term support level is at 15.4 HKD, with a second support level at 14.5 HKD if the price retraces. The first resistance level is at 16.5 HKD, and if this is breached, the stock could challenge the second resistance level at 17 HKD [4]. Product Performance - Recent performance of related derivative products has been strong, with products mentioned on May 22 showing a 6% increase within two days, highlighting the leverage effect of warrants and bull/bear certificates in a rising stock market [4]. Investment Products - For warrants, Citibank's call option (25498) has a high leverage with an exercise price of 16.9 HKD, suitable for investors expecting a breakout above 16.5 HKD. Morgan Stanley's call option (25657) offers a leverage of 11.4 times, appealing to aggressive investors [7]. - In terms of bear certificates, Citibank's bear certificate (57271) has a redemption price of 17.5 HKD and is suitable for short-term hedging, while UBS's bear certificate (57555) has a redemption price of 17.6 HKD, offering high leverage but with caution advised due to the resistance level at 16.5 HKD [7][8].

Investment Rating - The report assigns a basic factor and valuation rating of ★★★☆☆ to the company [4] Core Insights - The company is the second-largest online insurance intermediary in mainland China, holding a market share of 2.9% in the overall life insurance intermediary market as of 2023 [2] - Online intermediaries dominate the life insurance intermediary market in mainland China, accounting for 89.1% of total premiums in 2023 [2] - The company collaborates with over 110 insurance companies, including more than 70% of life insurance companies in mainland China, generating revenue primarily from commissions based on the premiums of policies distributed through its platform [2][3] Financial Data Summary - Revenue for the fiscal year ending December 31: - 2022: 8.06 billion RMB - 2023: 16.34 billion RMB - 2024: 13.87 billion RMB - Shareholder profit (loss) for the same period: - 2022: 1.31 billion RMB - 2023: -3.56 billion RMB - 2024: -1.36 billion RMB [4]

今日上午11點50分，平保(02318)盤中表現穩健，最新報46.7元，上漲0.65%，股價逼近日線圖的保利加通道頂部47.57元。同時周線圖的保利加通道頂部在 48.57元。 從技術面來看，10日均線(47.04元)與30日均線(45.33元)形成黃金交叉，MACD指標發出買入信號，但動能略顯溫和。RSI處於55的中性水平，顯示股價仍有 上行空間。關鍵支持位在44.9元（支持1）和44元（支持2），上方阻力則看48.4元（阻力1）和49.4元（阻力2）。 窩輪市場上，有投資者表示從周線和日k線上看是買入時機，後續會持續上漲，等50元再賣出。不過有看淡的投資者則認為站不穩55元，走勢仍弱勢。 回顧5月19日表現，平保相關衍生品表現亮眼。當日正股上漲2.19%，法巴認購證15999大漲16%，摩通牛證53834也有15%升幅，跑贏正股表現。 窩輪產品精選 現階段的窩輪選擇上，可關注花旗認購證13225，行使價49.93元，提供13.4倍槓桿，其最大優勢是溢價及引伸波幅均屬市場最低；摩利認購證15639則提供 12.9倍槓桿，行使價同樣為49.93元，引伸波幅較為理想。看跌方向的可考慮摩通認沽證28028和瑞銀認 ...

Company Recommendations - Leap Motor (9863) is recommended for purchase with a current price of 54.85 HKD and a short-term target price of 60.00 HKD, indicating a potential upside of 13.6% [2][9] - The company has seen a strong response to the launch of its SUV B10, with over 20,000 orders in the first month, which is expected to positively impact its Q2 2025 performance [9] - Leap Motor has formed strategic partnerships with international automotive group Stellantis and domestic giant FAW Group, enhancing its market position and potential for future growth [2][9] Financial Performance - Leap Motor's Q4 2024 results met market expectations, with revenue and net profit turning positive for the first time at 80 million RMB, achieving a gross margin of 13.3%, the highest since its inception [9] - The company has raised its sales guidance for 2025 from 500,000 to 500,000-600,000 units, projecting an annual growth of 87% based on a midpoint estimate of 550,000 units [9] - The first quarter of 2025 saw a year-on-year increase in deliveries by 1.6 times to 87,552 units, representing 16% of the updated annual sales guidance [9] Market Outlook - The market anticipates a compound annual growth rate (CAGR) of 49% for Leap Motor's revenue from FY24 to FY27, with the current price corresponding to a forecasted price-to-sales ratio of 1.2x for FY25, slightly below its historical average [9] - The company is expected to benefit from economies of scale and improved profitability as new vehicle sales continue to rise [9] Macro Environment - The Hang Seng Index is facing initial resistance at 23,000 points, influenced by recent announcements from the U.S. regarding tariffs and economic stimulus measures [2][5] - The Chinese government is expected to increase efforts to stabilize the economy, which may positively impact domestic demand and market sentiment [2][5]

香港交易及結算所有限公司、香港聯合交易所有限公司及新加坡證券交易所有限公司對本公告的內容概不負責，對其準確性或完整性 亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 （於英格蘭及威爾斯成立及註冊的有限責任公司，註冊編號為 01397169 （股份代號：2378） PRUDENTIAL PLC 第一季度業務表現的最新情況 隨附之公告由 Prudential plc 於以下日期發佈。 承董事會命 Prudential plc Tom Clarkson 公司秘書 二零二五年四月三十日，香港 截至本公告日期，Prudential plc 的董事會成員為： 持續實現營運及財務進展 — 第一季度新業務利潤上升 12% 截至二零二五年三月三十一日止三個月的表現摘要（按固定匯率基準）： 主席 Shriti Vadera 執行董事 Anil Wadhwani (華康堯) （執行總裁） 獨立非執行董事 Jeremy David Bruce Anderson (安德森) CBE、Arijit Basu、蔡淑君、路明、George David Sartorel、 M ...